Vantage Consulting Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $246K | Sell |
|
|||||
|
2023
Q4 | $290K | Buy |
|
|||||
|
2023
Q3 | $223K | Buy |
|
|||||
|
2023
Q2 | $227K | Buy |
|
|||||
|
2023
Q1 | $266K | Buy |
|
|||||
|
2022
Q4 | $243K | Sell |
|
|||||
|
2022
Q3 | $214K | Sell |
|
|||||
|
2022
Q2 | $270K | Buy |
|
|||||
|
2022
Q1 | $286K | Buy |
|
|||||
|
2021
Q4 | $258K | Buy |
|
|||||
|
2021
Q3 | $211K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $1K | Buy |
|